Lv1
10 积分 2022-12-17 加入
Review of dose justifications for antibody-drug conjugate approvals from clinical pharmacology perspective: A focus on exposure-response analyses
13小时前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
1天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
1天前
已完结
Current Status and Perspectives of Novel Radiopharmaceuticals with Heterologous Dual-targeted Functions: 2013–2023
1个月前
已完结
Clinical translation of radiotheranostics for precision oncology
1个月前
已完结
Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation
1个月前
已完结
皖公网安备34019202002308
